A Current Viewpoint of Lymphangioleiomyomatosis Supporting Immunotherapeutic Treatment OptionsDaniel F. Dilling, I. Caroline Le Poole, Jonathan M. Eby et al.|American Journal of Respiratory Cell and Molecular Biology|2011Cited by 18
Positioning Ganglioside D3 as an Immunotherapeutic Target in LymphangioleiomyomatosisEmily Gilbert, I. Caroline Le Poole, David G. Christensen et al.|American Journal Of Pathology|2013Cited by 15
Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in miceJonathan M. Eby, I. Caroline Le Poole, Levi Barse et al.|Cancer Immunology Immunotherapy|2016Cited by 6
GD3 Expression And Existing Immune Responses To The Antigen In LymphangioleiomyomatosisEmily Gilbert, I. C. LePoole, Jonathan M. Eby et al.|Unknown|2012Cited by 0
Vaccination with GD3 synthase provides tumor protection against melanoma in mice (P4461)Adam M. Hammer, I. Le Poole, Emily Gilbert et al.|The Journal of Immunology|2013Cited by 0